Merck’s $6.7bn Terns Pharmaceuticals buy puts CML drug TERN-701 in play as Keytruda patent cliff nears
Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Read More 2 minute read Pharma Industry News Novartis to acquire Advanced Accelerator Applications for $3.9bn to enhance oncology portfolio Novartis, the Switzerland-based global healthcare giant, has announced its decision to acquire Advanced Accelerator Applications (AAA), a French… bySrinathOctober 31, 2017
